A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC801 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(3L)BSC801 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}Sox21bf06429 and P{XP}CG4914d07633 insertion sites are 3L:14121351 ;14671335 and the cytological breakpoints predicted from these coordinates are 70D2;70E7.